With the exception of ID2, all the other immune genes (CD8a, IL2, IL7R, IL6, ID3, and CXCR3) were also highly expressed in low-risk neuroblastoma patients further confirming the significance of these immune genes in neuroblastoma cases with favorable outcomes (Figures S2A–S2G). This evidence concerns the gene IL7R and neuroblastoma.